Comorbidities shouldn’t exclude patients from immunotherapy: expert

New research suggests oncologists can feel more confident about using immunotherapy to treat cancer in patients with a range of co-morbidities including autoimmune diseases, a conference has heard. Dr Alex Menzies, a medical oncologist at Melanoma Institute Australia and Royal North Shore Hospital, told the COSA Annual Scientific Meeting that data garnered through clinical trials has not ...

Already a member?

Login to keep reading.

© 2021 the limbic